Skip to main content
Cellid Co., Ltd. logo

Cellid Co., Ltd. — Investor Relations & Filings

Ticker · 299660 ISIN · KR7299660001 KO Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2022-03-21 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 299660

About Cellid Co., Ltd.

http://www.cellid.co.kr

Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.

Recent filings

Filing Released Lang Actions
전환가액의조정(제2회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in the market price of the company's shares. This type of disclosure relates to changes in the company's capital structure and financial instruments. Among the provided categories, 'CAP' (Capital/Financing Update) is the most appropriate classification as it covers updates on financing activities and capital structure changes, including adjustments to convertible debt instruments.
2022-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides the audit opinion (unqualified/proper), key financial data, and auditor information. While it contains financial data, it is a summary disclosure of the audit results rather than the full 10-K annual report or a standalone audit report document. According to the filing definitions, this fits the 'Audit Report / Information' (AR) category as it specifically reports on the audit outcome and financial statements. FY 2021
2022-03-15 Korean
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company 'Cellid' for the 16th fiscal year (2021). It contains comprehensive financial and operational information, including company overview, history, capital structure, business description, and detailed financial data. This aligns with the definition of an Annual Report (10-K) in the provided schema, as it is the official yearly report covering company activity and performance. FY 2021
2022-03-15 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including agenda items (such as the appointment of an auditor), voting procedures, and financial statements for the 16th fiscal year. This document is a formal solicitation of proxies from shareholders for the meeting, which falls under the Proxy Solicitation & Information Statement category.
2022-03-11 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by Cellid Co., Ltd. It includes details about the meeting date, location, agenda items (such as director/auditor appointments and financial statement approval), and voting procedures (including electronic voting). It also contains 'Management Reference Materials' (경영참고사항) which provide business overviews and industry analysis. This document is a standard proxy statement/notice for a shareholder meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-03-11 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing in South Korea (often referred to as the 5% rule filing). It details changes in share ownership by major shareholders and their special relations, including specific transaction dates and methods (e.g., '장내매도' - open market sale). Since it is a formal regulatory disclosure regarding significant shareholding thresholds, it falls under the 'Major Shareholding Notification' category.
2022-03-08 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.